Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.
作者信息
Terpos Evangelos, Trougakos Ioannis P, Apostolakou Filia, Charitaki Ioanna, Sklirou Aimilia D, Mavrianou Nefeli, Papanagnou Eleni-Dimitra, Liacos Christine-Ivy, Gumeni Sentiljana, Rentziou Gianna, Korompoki Eleni, Papassotiriou Ioannis, Dimopoulos Meletios A
机构信息
Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
出版信息
Am J Hematol. 2021 Jul 1;96(7):E257-E259. doi: 10.1002/ajh.26185. Epub 2021 Apr 24.
Abstract
摘要
相似文献
1
Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.接种BNT162b2 mRNA疫苗后，医护人员和八旬老人针对新冠病毒的年龄和性别依赖性抗体反应。
Am J Hematol. 2021 Jul 1;96(7):E257-E259. doi: 10.1002/ajh.26185. Epub 2021 Apr 24.
2
Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming.有或无前新冠病毒感染启动的情况下，SARS-CoV-2疫苗BNT162b2的抗体依赖性中和能力
J Intern Med. 2021 Dec;290(6):1272-1274. doi: 10.1111/joim.13366. Epub 2021 Aug 2.
3
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.在先前感染过 SARS-CoV-2 的医护人员中，单次接种 ChAdOx1 nCoV-19 疫苗后的抗体反应。
EBioMedicine. 2021 Aug;70:103523. doi: 10.1016/j.ebiom.2021.103523. Epub 2021 Aug 12.
4
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).肾移植受者对 BNT162b2（辉瑞-生物科技）接种 SARS-CoV-2 疫苗的体液免疫反应受损。
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
5
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2.先前感染过 SARS-CoV-2 的个体对 BNT162b2 mRNA 疫苗的抗体反应。
Nat Med. 2021 Jun;27(6):981-984. doi: 10.1038/s41591-021-01325-6. Epub 2021 Apr 1.
6
Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine.BNT162b2 与 mRNA-1273 疫苗接种者的年龄与 SARS-CoV-2 抗体反应比较。
JAMA Netw Open. 2021 Sep 1;4(9):e2124331. doi: 10.1001/jamanetworkopen.2021.24331.
7
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.立陶宛血液系统恶性肿瘤患者的 BNT162b2 COVID-19 mRNA 疫苗免疫原性和早期临床结局：一项全国前瞻性队列研究。
Lancet Haematol. 2021 Aug;8(8):e583-e592. doi: 10.1016/S2352-3026(21)00169-1. Epub 2021 Jul 2.
8
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.既往自然感染人群中新型冠状病毒2型（SARS-CoV-2）的抗体反应
N Engl J Med. 2021 Jul 1;385(1):90-92. doi: 10.1056/NEJMc2103825. Epub 2021 Apr 14.
9
Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose.骨髓瘤老年患者在接种第一剂BNT162b2疫苗后对新冠病毒的中和抗体反应较低。
Blood. 2021 Jul 1;137(26):3674-3676. doi: 10.1182/blood.2021011904.
10
Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.在先前感染过 SARS-CoV-2 的医护人员中，单次疫苗接种后的结合抗体和中和抗体滴度。
JAMA. 2021 Apr 13;325(14):1467-1469. doi: 10.1001/jama.2021.3341.
引用本文的文献
1
Anti-SARS-CoV-2 Antibody Levels in a Cohort of Health Care Workers Before and After the Omicron Wave in Canada.加拿大奥密克戎毒株浪潮前后一组医护人员体内的抗新冠病毒 2 抗体水平
J Assoc Med Microbiol Infect Dis Can. 2025 May 29;10(2):127-145. doi: 10.3138/jammi-2024-0029. eCollection 2025 Jun.
2
Comparing Antibody Responses to Homologous vs. Heterologous COVID-19 Vaccination: A Cross-Sectional Analysis in an Urban Bangladeshi Population.比较新冠病毒疫苗同源接种与异源接种后的抗体反应：孟加拉国城市人口的横断面分析
Vaccines (Basel). 2025 Jan 13;13(1):67. doi: 10.3390/vaccines13010067.
3
Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies.追踪免疫：增加新冠病毒加强针的接种次数可延长抗受体结合域（RBD）抗体和抗RBD中和抗体的存续时间。
Vaccines (Basel). 2025 Jan 12;13(1):61. doi: 10.3390/vaccines13010061.
4
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19.年龄差异会影响腺病毒和 mRNA 疫苗对 COVID-19 诱导的适应性免疫反应。
Nat Aging. 2024 Aug;4(8):1121-1136. doi: 10.1038/s43587-024-00644-w. Epub 2024 Jun 25.
5
High Concentration of Anti-SARS-CoV-2 Antibodies 2 Years after COVID-19 Vaccination Stems Not Only from Boosters but Also from Widespread, Often Unrecognized, Contact with the Virus.新冠病毒疫苗接种两年后出现的高浓度抗SARS-CoV-2抗体不仅源于加强针，还源于广泛的、通常未被识别的与病毒的接触。
Vaccines (Basel). 2024 Apr 28;12(5):471. doi: 10.3390/vaccines12050471.
6
Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination.新冠病毒加强疫苗接种后医护人员队列的后续严重急性呼吸综合征冠状病毒2血清学研究
BMC Infect Dis. 2024 Apr 24;24(1):436. doi: 10.1186/s12879-024-09338-5.
7
SARS-CoV-2 booster vaccine dose significantly extends humoral immune response half-life beyond the primary series.SARS-CoV-2 加强疫苗接种剂量可显著延长体液免疫应答半衰期，超过初级系列。
Sci Rep. 2024 Apr 18;14(1):8426. doi: 10.1038/s41598-024-58811-3.
8
A Longitudinal Study in Tunisia to Assess the Anti-RBD IgG and IgA Responses Induced by Three Different COVID-19 Vaccine Platforms.突尼斯的一项纵向研究，以评估三种不同新冠疫苗平台诱导的抗受体结合域免疫球蛋白G和免疫球蛋白A反应。
Trop Med Infect Dis. 2024 Mar 13;9(3):61. doi: 10.3390/tropicalmed9030061.
9
A Potential Association between Abdominal Obesity and the Efficacy of Humoral Immunity Induced by COVID-19 and by the AZD1222, Convidecia, BNT162b2, Sputnik V, and CoronaVac Vaccines.腹部肥胖与新型冠状病毒肺炎及阿斯利康新冠疫苗（AZD1222）、康希诺生物新冠疫苗（Convidecia）、辉瑞新冠疫苗（BNT162b2）、俄罗斯卫星V新冠疫苗（Sputnik V）和科兴新冠疫苗（CoronaVac）诱导的体液免疫效果之间的潜在关联。
Vaccines (Basel). 2024 Jan 15;12(1):88. doi: 10.3390/vaccines12010088.
10
Robust memory humoral immune response to SARS-CoV-2 in the tonsils of adults and children.成人和儿童扁桃体中对 SARS-CoV-2 的强大记忆体液免疫反应。
Front Immunol. 2023 Dec 11;14:1291534. doi: 10.3389/fimmu.2023.1291534. eCollection 2023.
本文引用的文献
1
Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.在先前感染过 SARS-CoV-2 的医护人员中，单次疫苗接种后的结合抗体和中和抗体滴度。
JAMA. 2021 Apr 13;325(14):1467-1469. doi: 10.1001/jama.2021.3341.
2
First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff.熟练护理机构居民和工作人员中首剂新冠疫苗接种覆盖率
JAMA. 2021 Apr 27;325(16):1670-1671. doi: 10.1001/jama.2021.2352.
3
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications.对 SARS-CoV-2 生命周期、病理生理学的深入了解，以及针对 COVID-19 临床并发症的合理治疗方法。
J Biomed Sci. 2021 Jan 12;28(1):9. doi: 10.1186/s12929-020-00703-5.
4
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
5
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.一种基于抗体介导的 ACE2-刺突蛋白-蛋白相互作用阻断的 SARS-CoV-2 假病毒中和试验。
Nat Biotechnol. 2020 Sep;38(9):1073-1078. doi: 10.1038/s41587-020-0631-z. Epub 2020 Jul 23.
6
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model.在小动物模型中分离出有效的 SARS-CoV-2 中和抗体并预防疾病。
Science. 2020 Aug 21;369(6506):956-963. doi: 10.1126/science.abc7520. Epub 2020 Jun 15.
Zotero 插件